-
1
-
-
0035400270
-
Mechanisms of resistance to cisplatin
-
Kartalou M and Essigmann JM: Mechanisms of resistance to cisplatin. Mutat Res 478: 23-43, 2001.
-
(2001)
Mutat Res
, vol.478
, pp. 23-43
-
-
Kartalou, M.1
Essigmann, J.M.2
-
3
-
-
0035381215
-
The mechanism of cisplatin-resistance in ovarian cancer
-
Kikuchi Y: The mechanism of cisplatin-resistance in ovarian cancer. Hum Cell 14: 115-133, 2001.
-
(2001)
Hum Cell
, vol.14
, pp. 115-133
-
-
Kikuchi, Y.1
-
4
-
-
0024948493
-
Differential gene expression in human cancer cells resistant to cisplatin
-
Scanlon KJ, Kashani-Sabet M and Miyachi H: Differential gene expression in human cancer cells resistant to cisplatin. Cancer Invest 7: 581-587, 1989.
-
(1989)
Cancer Invest
, vol.7
, pp. 581-587
-
-
Scanlon, K.J.1
Kashani-Sabet, M.2
Miyachi, H.3
-
5
-
-
0032169105
-
Cellular and molecular determinations of cisplatin resistance
-
Perez RP: Cellular and molecular determinations of cisplatin resistance. Eur J Cancer 34: 1535-1542, 1998.
-
(1998)
Eur J Cancer
, vol.34
, pp. 1535-1542
-
-
Perez, R.P.1
-
6
-
-
0030578452
-
Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines
-
Johnson SW, Shen D, Pastan I, Gottesman MM and Hamilton TC: Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines. Exp Cell Res 226: 133-139, 1996.
-
(1996)
Exp Cell Res
, vol.226
, pp. 133-139
-
-
Johnson, S.W.1
Shen, D.2
Pastan, I.3
Gottesman, M.M.4
Hamilton, T.C.5
-
7
-
-
0024263756
-
Comparison of lipid content, surface membrane fluidity, and temperature dependence of ds-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
-
Mann SC, Andrews PA and Howell SB: Comparison of lipid content, surface membrane fluidity, and temperature dependence of ds-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Anticancer Res 8: 1211-1215, 1988.
-
(1988)
Anticancer Res
, vol.8
, pp. 1211-1215
-
-
Mann, S.C.1
Andrews, P.A.2
Howell, S.B.3
-
8
-
-
0037112421
-
Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper
-
Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, Kuo YM, Rochdi M and Howell SB: Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 62: 6559-6565, 2002.
-
(2002)
Cancer Res
, vol.62
, pp. 6559-6565
-
-
Katano, K.1
Kondo, A.2
Safaei, R.3
Holzer, A.4
Samimi, G.5
Mishima, M.6
Kuo, Y.M.7
Rochdi, M.8
Howell, S.B.9
-
9
-
-
1442335459
-
Cross-resistance to cisplatin in cells with acquired resistance to copper
-
Safaei R, Katano K, Samimi G, Naerdemann W, Stevenson JL, Rochdi M and Howell SB: Cross-resistance to cisplatin in cells with acquired resistance to copper. Cancer Chemother Pharmacol 53: 239-246, 2004.
-
(2004)
Cancer Chemother Pharmacol
, vol.53
, pp. 239-246
-
-
Safaei, R.1
Katano, K.2
Samimi, G.3
Naerdemann, W.4
Stevenson, J.L.5
Rochdi, M.6
Howell, S.B.7
-
10
-
-
0037195066
-
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
-
Ishida S, Lee J, Thiele DJ and Herskowitz I: Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99: 14298-14302, 2002.
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 14298-14302
-
-
Ishida, S.1
Lee, J.2
Thiele, D.J.3
Herskowitz, I.4
-
11
-
-
4844224830
-
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells
-
Holzer AK, Katano K, Klomp LW and Howell SB: Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin Cancer Res 10: 6744-6749, 2004.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 6744-6749
-
-
Holzer, A.K.1
Katano, K.2
Klomp, L.W.3
Howell, S.B.4
-
12
-
-
10644269449
-
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Clit Rev Oncol
-
Safaei R and Howell SB: Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Clit Rev Oncol Hematol 53: 13-23, 2005.
-
(2005)
Hematol
, vol.53
, pp. 13-23
-
-
Safaei, R.1
Howell, S.B.2
-
13
-
-
0347447284
-
Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients
-
Samimi G, Varki NM, Wilczynski S, Safaei R, Alberts DS and Howell SB: Increase in expression of the copper transporter ATP7A during platinum drug-based treatment is associated with poor survival in ovarian cancer patients. Clin Cancer Res 9: 5853-5859, 2003.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5853-5859
-
-
Samimi, G.1
Varki, N.M.2
Wilczynski, S.3
Safaei, R.4
Alberts, D.S.5
Howell, S.B.6
-
14
-
-
0023185508
-
Cis-diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: Quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II)
-
Fichtinger-Schepman AMJ, von Oosterom AT, Lohman PHM and Berends F: Cis-diamminedichloroplatinum(II)-induced DNA adducts in peripheral leukocytes from seven cancer patients: quantitative immunochemical detection of the adduct induction and removal after a single dose of cis-diamminedichloroplatinum(II). Cancer Res 47: 3000-3004, 1987.
-
(1987)
Cancer Res
, vol.47
, pp. 3000-3004
-
-
Fichtinger-Schepman, A.M.J.1
von Oosterom, A.T.2
Lohman, P.H.M.3
Berends, F.4
-
15
-
-
0028158014
-
Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro
-
Oldenburg J, Begg AC, von Vugt MJ, Ruevekamp M, Schornagel JH, Pinedo HM and Los G: Characterization of resistance mechanisms to cis-diamminedichloroplatinum(II) in three sublines of the CC531 colon adenocarcinoma cell line in vitro. Cancer Res 54: 487-493, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 487-493
-
-
Oldenburg, J.1
Begg, A.C.2
von Vugt, M.J.3
Ruevekamp, M.4
Schornagel, J.H.5
Pinedo, H.M.6
Los, G.7
-
16
-
-
0025775323
-
Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation
-
Parker RJ, Eastman A, Bostick-Bruton F and Reed E: Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation. J Clin Invest 87: 772-777, 1991.
-
(1991)
J Clin Invest
, vol.87
, pp. 772-777
-
-
Parker, R.J.1
Eastman, A.2
Bostick-Bruton, F.3
Reed, E.4
-
17
-
-
0025093554
-
Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells
-
Mann SC, Andrews PA and Howell SB: Short-term cis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Chemother Pharmacol 25: 236-240, 1990.
-
(1990)
Cancer Chemother Pharmacol
, vol.25
, pp. 236-240
-
-
Mann, S.C.1
Andrews, P.A.2
Howell, S.B.3
-
18
-
-
0025542155
-
The role of glutathione in drug resistance
-
Ozols RF, O'Dwyer PJ, Hamilton TC and Young RC: The role of glutathione in drug resistance. Cancer Treatment Rev 17(Suppl. A): 45-50, 1990.
-
(1990)
Cancer Treatment Rev
, vol.17
, Issue.SUPPL. A
, pp. 45-50
-
-
Ozols, R.F.1
O'Dwyer, P.J.2
Hamilton, T.C.3
Young, R.C.4
-
19
-
-
0023696141
-
Overexpression of methallothionein confers resistance to anticancer drugs
-
Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH and Lazo JS: Overexpression of methallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988.
-
(1988)
Science
, vol.241
, pp. 1813-1815
-
-
Kelley, S.L.1
Basu, A.2
Teicher, B.A.3
Hacker, M.P.4
Hamer, D.H.5
Lazo, J.S.6
-
20
-
-
0027939445
-
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells
-
Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, and Hamilton TC: Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells. Cancer Res 54: 5911-5916, 1994.
-
(1994)
Cancer Res
, vol.54
, pp. 5911-5916
-
-
Johnson, S.W.1
Swiggard, P.A.2
Handel, L.M.3
Brennan, J.M.4
Godwin, A.K.5
Ozols, R.F.6
Hamilton, T.C.7
-
21
-
-
0024238957
-
Enhanced DNA repair and resistance to cisplatin in human ovarian cancer
-
Lai GM, Ozols RF, Smyth JF, Young RC and Hamilton TC: Enhanced DNA repair and resistance to cisplatin in human ovarian cancer. Biochem Pharmacol 37: 4597-4600, 1998.
-
(1998)
Biochem Pharmacol
, vol.37
, pp. 4597-4600
-
-
Lai, G.M.1
Ozols, R.F.2
Smyth, J.F.3
Young, R.C.4
Hamilton, T.C.5
-
22
-
-
0023750017
-
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines
-
Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M and Hamilton TC: Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum(II) in human ovarian cancer cell lines. Cancer Res 48: 5713-5716, 1988.
-
(1988)
Cancer Res
, vol.48
, pp. 5713-5716
-
-
Masuda, H.1
Ozols, R.F.2
Lai, G.M.3
Fojo, A.4
Rothenberg, M.5
Hamilton, T.C.6
-
23
-
-
0027233829
-
Cellular accumulation of the anticancer agent cisplatin: A review
-
Gately DP and Howell SB: Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67: 1171-1176, 1993.
-
(1993)
Br J Cancer
, vol.67
, pp. 1171-1176
-
-
Gately, D.P.1
Howell, S.B.2
-
24
-
-
0025183102
-
Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine
-
Binks SP and Dobrota M: Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine. Biochem Pharmacol 40: 1329-1336, 1990.
-
(1990)
Biochem Pharmacol
, vol.40
, pp. 1329-1336
-
-
Binks, S.P.1
Dobrota, M.2
-
25
-
-
0023183762
-
Decreased cisplatin uptake by resistant L1210 leukemia cells
-
Hromas RA, North JA and Burns CP: Decreased cisplatin uptake by resistant L1210 leukemia cells. Cancer Lett 36: 197-201, 1987.
-
(1987)
Cancer Lett
, vol.36
, pp. 197-201
-
-
Hromas, R.A.1
North, J.A.2
Burns, C.P.3
-
26
-
-
0036751805
-
Electron microscopy analysis of early localization of cisplatin in ovarian carcinama cells
-
Beretta GL, Righetti SC, Lombardi L, Zunino F and Perego P: Electron microscopy analysis of early localization of cisplatin in ovarian carcinama cells. Ultrastruct Pathol 26: 331-334, 2002.
-
(2002)
Ultrastruct Pathol
, vol.26
, pp. 331-334
-
-
Beretta, G.L.1
Righetti, S.C.2
Lombardi, L.3
Zunino, F.4
Perego, P.5
-
27
-
-
0025860926
-
+-adenosine triphosphatase in the accumulation of ris-diamminedichloroplatinum(II) in human ovarian carcinoma cells
-
+-adenosine triphosphatase in the accumulation of ris-diamminedichloroplatinum(II) in human ovarian carcinoma cells. Cancer Res 51: 3677-3681, 1991.
-
(1991)
Cancer Res
, vol.51
, pp. 3677-3681
-
-
Andrew, P.A.1
Mann, S.C.2
Huynh, H.H.3
Albright, K.D.4
-
28
-
-
0026752490
-
Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells
-
Andrews PA and Albright KD: Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Cancer Res 52: 1895-1901, 1992.
-
(1992)
Cancer Res
, vol.52
, pp. 1895-1901
-
-
Andrews, P.A.1
Albright, K.D.2
-
29
-
-
0025845124
-
Potentiation of cisplatin against sensitive and resistant human ovarian cancer cell lines by amphotericin B
-
Masuda H, Tanaka T, Kido A and Kusaba I: Potentiation of cisplatin against sensitive and resistant human ovarian cancer cell lines by amphotericin B. Cancer J 4: 119-124, 1991.
-
(1991)
Cancer J
, vol.4
, pp. 119-124
-
-
Masuda, H.1
Tanaka, T.2
Kido, A.3
Kusaba, I.4
-
30
-
-
33644674732
-
+-ATPase α1 subunit in the intracellular accumulation of cisplatin
-
+-ATPase α1 subunit in the intracellular accumulation of cisplatin. Cancer Chemother Pharmacol 57: 84-90, 2006.
-
(2006)
Cancer Chemother Pharmacol
, vol.57
, pp. 84-90
-
-
Kishimoto, S.1
Kawazoe, Y.2
Ikeno, M.3
Saitoh, M.4
Nakano, Y.5
Nishi, Y.6
Fukushima, S.7
Takeuchi, Y.8
-
32
-
-
0034162887
-
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance
-
Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T and Akiyama S: Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res 60: 1312-1316, 2000.
-
(2000)
Cancer Res
, vol.60
, pp. 1312-1316
-
-
Komatsu, M.1
Sumizawa, T.2
Mutoh, M.3
Chen, Z.S.4
Terada, K.5
Furukawa, T.6
Yang, X.L.7
Gao, H.8
Miura, N.9
Sugiyama, T.10
Akiyama, S.11
-
33
-
-
0141514433
-
Copper (II) protects yeast against the toxicity of cisplatin independently of the induction of metallothionein and the inhibition of platinum uptake
-
Ohashi K, Kajiya K, Inaba S, Hasegawa T, Seko Y, Furuchi T and Naganuma A: Copper (II) protects yeast against the toxicity of cisplatin independently of the induction of metallothionein and the inhibition of platinum uptake. Biochem Biophys Res Commun 310: 148-152, 2003.
-
(2003)
Biochem Biophys Res Commun
, vol.310
, pp. 148-152
-
-
Ohashi, K.1
Kajiya, K.2
Inaba, S.3
Hasegawa, T.4
Seko, Y.5
Furuchi, T.6
Naganuma, A.7
-
34
-
-
28744457611
-
Copper treatment alters the barrier functions of human intestinal Caco-2 cells
-
Liu ZW, Chen JL and Chen BH: Copper treatment alters the barrier functions of human intestinal Caco-2 cells. Zhonghua Yu Fang Yi Xue Za Zhi 38: 406-410, 2004.
-
(2004)
Zhonghua Yu Fang Yi Xue Za Zhi
, vol.38
, pp. 406-410
-
-
Liu, Z.W.1
Chen, J.L.2
Chen, B.H.3
-
36
-
-
0028040512
-
Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: Genomic organization, alternative, splicing and structure/function predictions
-
Petrukhin K, Lutsenko S, Chernov I, Ross BM, Kaplan JH and Gilliam TC: Characterization of the Wilson disease gene encoding a P-type copper transporting ATPase: genomic organization, alternative, splicing and structure/function predictions. Hum Mol Genet 3: 1647-1656, 1994.
-
(1994)
Hum Mol Genet
, vol.3
, pp. 1647-1656
-
-
Petrukhin, K.1
Lutsenko, S.2
Chernov, I.3
Ross, B.M.4
Kaplan, J.H.5
Gilliam, T.C.6
-
37
-
-
10644270416
-
Expression of the copper transporter ATP7A modulates cisplatin transport
-
Samimi G, Safaei R, Katano K, Naerdemann W, Holzer AK and Howell SB: Expression of the copper transporter ATP7A modulates cisplatin transport. Proc Am Assoc Cancer Res 43: 423, 2002.
-
(2002)
Proc Am Assoc Cancer Res
, vol.43
, pp. 423
-
-
Samimi, G.1
Safaei, R.2
Katano, K.3
Naerdemann, W.4
Holzer, A.K.5
Howell, S.B.6
-
38
-
-
3042663282
-
Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B
-
Samimi G, Katano K, Holzer AK, Safaei R and Howell SB: Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B. Mol Pharmacol 66: 25-32, 2004.
-
(2004)
Mol Pharmacol
, vol.66
, pp. 25-32
-
-
Samimi, G.1
Katano, K.2
Holzer, A.K.3
Safaei, R.4
Howell, S.B.5
-
39
-
-
3242734736
-
Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells
-
Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M and Howell SB: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin Cancer Res 10: 4661-4669, 2004.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 4661-4669
-
-
Samimi, G.1
Safaei, R.2
Katano, K.3
Holzer, A.K.4
Rochdi, M.5
Tomioka, M.6
Goodman, M.7
Howell, S.B.8
-
40
-
-
33644767850
-
Role of copper transporters in the uptake and efflux of platinum containing drugs
-
Safaei R: Role of copper transporters in the uptake and efflux of platinum containing drugs. Cancer Lett 234: 34-39, 2006.
-
(2006)
Cancer Lett
, vol.234
, pp. 34-39
-
-
Safaei, R.1
-
41
-
-
0036840625
-
The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae
-
Lin X, Okuda T, Holzer A and Howell SB: The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol Phamacol 62: 1154-1159, 2002.
-
(2002)
Mol Phamacol
, vol.62
, pp. 1154-1159
-
-
Lin, X.1
Okuda, T.2
Holzer, A.3
Howell, S.B.4
-
42
-
-
4844228226
-
The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells
-
Holzer AK, Samimi G, Katano K, Naerdemann W, Lin X, Safaei R and Howell SB: The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells. Mol Pharmacol 66: 817-823, 2004.
-
(2004)
Mol Pharmacol
, vol.66
, pp. 817-823
-
-
Holzer, A.K.1
Samimi, G.2
Katano, K.3
Naerdemann, W.4
Lin, X.5
Safaei, R.6
Howell, S.B.7
-
43
-
-
0036606750
-
Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1)
-
Klomp AEM, Tops BBJ, Berg IET, Berger R and Klomp LWJ: Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1). Biocem J 364: 497-505, 2002.
-
(2002)
Biocem J
, vol.364
, pp. 497-505
-
-
Klomp, A.E.M.1
Tops, B.B.J.2
Berg, I.E.T.3
Berger, R.4
Klomp, L.W.J.5
-
44
-
-
12344314253
-
Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells
-
Song IS, Savaraj N, Siddik ZH, Liu P, Wei Y, Wu CJ and Kuo MT: Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells. Mol Cancer Ther 3: 1543-1549, 2004.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 1543-1549
-
-
Song, I.S.1
Savaraj, N.2
Siddik, Z.H.3
Liu, P.4
Wei, Y.5
Wu, C.J.6
Kuo, M.T.7
-
45
-
-
2942573029
-
Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells
-
Beretta GL, Gatti L, Tinelli S, Corna E, Colangelo D, Zunino F and Perego P: Cellular pharmacology of cisplatin in relation to the expression of human copper transporter CTR1 in different pairs of cisplatin-sensitive and -resistant cells. Biochem Pharmacol 68: 283-291, 2004.
-
(2004)
Biochem Pharmacol
, vol.68
, pp. 283-291
-
-
Beretta, G.L.1
Gatti, L.2
Tinelli, S.3
Corna, E.4
Colangelo, D.5
Zunino, F.6
Perego, P.7
|